Right atrial thrombus: a complication of total parenteral nutrition in an adult
Complications of total parenteral nutrition include sepsis, thrombosis, and metabolic abnormalities. Although several cases ofright atrial thrombosis as a complication of total parenteral nutrition have been described in premature infants,t4 it has not, to our knowledge, been described in adults.
We report such a case in an adult.
Case report
A 17 year old youth was admitted with a suspected infection of his central venous feeding line. From June 1983 he had received home parenteral nutrition after resection of virtually all his small intestine because of gangrene caused by a volvulus. He had been well until two days before his admission, when he developed a fever and rigors. On examination he was feverish with a temperature of 38°C. His heart sounds were normal and his chest clear. Blood cultures grew Staphylococcus epidernidis and he was treated with flucloxacillin. His fever resolved and he restarted intravenous feeding.
He was readmitted two weeks later with a sudden onset ofdyspnoea, fever, and dry cough. On examination he was feverish with a temperature of 39-70C. His pulse rate was 130/min and his heart sounds were normal. He had bilateral basal crepitations. An electrocardiogram showed sinus tachycardia and a chest x ray film showed a decreased vascularity in the right, mid, and lower zones. A perfusion-ventilation scan showed a perfusion defect in the right lower zone that was suggestive of a pulmonary embolus. His feeding line was removed and two 1 _1 I_ 1 1 _ l~~~~~~~a Tw dImesoa ecoadiga aical vie ofurcabsshwn atiu, an T trcsi valve| dimensional echocardiography was performed. It showed a large mass in the right atrium (figure) attached to the base of the atrium with a long tail protruding intermittently through the tricuspid valve into the right ventricle. The right atrium and ventricle were moderately dilated. Blood cultures grew Staph epidermidis and he was treated with antibiotics and heparin.
He was referred for surgery. A right sternotomy was performed, which showed that the right side of the heart was moderately dilated. In the right atrium was a fairly large clot attached with a wide base to the right atrial wall. It had a long tail with a bulbous end protruding through the tricuspid valve into the right ventricle. Most of the right atrial wall was thickened. The clot was excised together with a large section of the right atrial wall. The wall was repaired with a patch of bovine pericardium. Histological examination showed that the mass was composed of fibrin, and no organisms were grown. He made an excellent recovery. The antibiotics were discontinued and he was given oral anticoagulation treatment. A Broviac feeding line was inserted and at the time of writing he was continuing with total parenteral feeding.
Comment
Although National survey of use of the Angelchik antireflux prosthesis
The Angelchik antireflux prosthesis is a silicone prosthetic implant shaped like a horseshoe that is tied around the distal oesophagus beneath the diaphragm. It has been used in the United Kingdom for a little over five years. Its insertion has been claimed to be technically uncomplicated and associated with few complications,' and it has been reported to achieve good control of refluix.2 Several serious complications have been reported,3-5 but only a small number of patients have been studied so it is difficult to assess the true incidence of complications. The aim of this study was to investigate the experience of general surgeons using the Angelchik antireflux prosthesis in the United Kingdom and to determine the incidence and nature of serious complications and the rate of removal.
Methods and results
A brief questionnaire with a letter requesting cooperation was circulated to all 1250 general surgeons in the United Kingdom on the register of a commercial mailing house. The surgeons were not required to identify themselves. Information was obtained on experience with the Angelchik prosthesis by the questions: "Have you ever used the Angelchik prosthesis? How many prostheses have you put in? Have you had any complications?" Specific questions were included about severe dysphagia, erosion into the gastrointestinal tract, and any other complications. The surgeons were asked if they had removed any Angelchik prostheses and, if so, how many and for what reasons. They were also asked how many operations for hiatus hernia and reflux they did yearly.
Five hundred and thirty (42%) surgeons replied, of whom 134 (25%) had used the prosthesis and implanted a total of 1013 (about three quarters ofthe total sales in the United Kingdom at that time). The mean (2 SE) number of prostheses implanted by each surgeon was 7-6 (1-8). Surgeons who used the Angelchik prosthesis performed a mean of 8-2 (1-2) antireflux operations yearly whereas non-users performed 3-6 (0-4) operations.
Forty six surgeons reported that complications had occurred in 91 (9%) patients; severe dysphagia was by far the commonest complication (66 patients), but nine patients had developed the serious complication of erosion. Thoracic migration was seen in six patients and distal migration in one. Disruption of the tapes, which was a problem with an early version of the prosthesis, was seen in three patients. Only two patients apparently developed appreciable sepsis. Oesophageal perforation early in the postoperative period, as opposed to late erosion, was seen in one patient. Fatal pericarditis due to erosion ofthe prosthesis was seen in one patient and atrial compression in one.
Fifty two prostheses (5-1%) were removed, and again by far the commonest reason was dysphagia (27 cases), followed by erosion (nine), migration (seven), disruption of the tapes (three), and sepsis (two).
Four prostheses were removed because of pain, oesophageal perforation, atrial compression, and pericarditis.
The experience of the surgeon did not seem to relate to postoperative complications or rate of removal. The surgeons who had implanted five prostheses or fewer had a rate of removal of 7% compared with 5-5% for surgeons who had used more than 20.
Comment
With the increasing use of the Angelchik antireflux prosthesis complications are now being reported. We believe that the results of new procedures should be assessed in widely based studies such as ours rather than solely on the results of experienced enthusiasts operating in teaching centres. Although only 42% of surgeons replied to our questionnaire, those using the prosthesis accounted for about three quarters of the total number of prostheses sold in the United Kingdom at that time, and this is by far the largest collection of such data in the world.
Surgeons who used the Angelchik prosthesis performed more antireflux procedures each year than non-users, and the prosthesis accounted for only a part of their experience. More than half of the prostheses were inserted by surgeons who had performed the procedure 20 times or less often, but the rate of removal in this group was not different from that among the 18 surgeons who had done more than 20 procedures and were thus more experienced. The serious complications seen included severe dysphagia, erosion, and migration; these complications and other less frequent problems necessitated the removal of 5% of the prostheses. This is comparable with the revision rate after the Nissen procedure. The long term effects of the Angelchik procedure are not yet known, and the rates of complication and removal may increase with time. Long term follow up of these patients is clearly required, and we seek the continued cooperation of surgeons in the United Kingdom. Does screening high risk dental patients for hepatitis B virus protect dentists?
Markers ofpast or current infection with hepatitis B virus (HBV) are present in up to 24% of dental surgeons and technicians'; the risk of infection correlates with age and the nature of exposure.2 Current recommendations are that patients from well defined high risk groups should be screened before having dental treatment so that appropriate precautions can be taken.3 We evaluated the efficiency of such screening in a dental clinic in an area with a high prevalence of drug abuse and a substantial proportion of patients who were born, or descended from people born, in places where HBV is endemic.
Methods and results
Dentists at the King's College School of Dentistry were advised to screen patients from high risk groups for infection with HBV according to recommended guidelines.3 Altogether 2000 consecutive requests for screening (September 1983 to July 1986 were analysed for the reason that the request was made and whether hepatitis B surface antigen (HBsAg) was present in serum. Over the same period 53000 patients were treated on 409 000 occasions without screening. Patients known to be positive for HBsAg were excluded from the analysis. HBsAg was sought by radioimmunoassay and positive results confirmed by reverse passive haemagglutination.
Sixty two (3-1%) of the high risk patients were positive for HBsAg ( which was a lower proportion than we had expected. The two main;reasons for requesting screening-that the patients had tattoos or a history of hepatitis or jaundice-identified only 13 carriers of HBV in 1338 patients screened; of these, three were later found to be homosexuals or intravenous drug addicts.
Comment
Estimates ofthe prevalence ofcarriers ofHBV in the United Kingdom are based on results from blood donors, which may not accurately reflect the contribution of race and excludes people with liver disease. Thus estimates of the prevalence as being 0-1% to 0-4% may underestimate the problem, particularly in inner city areas; up to 1I5% ofunselected patients admitted to North American hospitals4 and 2-1% of pregnant women in Holland5 are positive for HBsAg. If we make the conservative estimate that 0'4% of the local population are positive for HBsAg the contrast between the expected number (220) and the actual number (62) of carriers of HBV identified is disconcerting, and the true difference is probably even greater. The problems in identifying three important groups probably account for the discrepancy: only three homosexuals were screened in 55 000 patients; more people from South East Asia were screened than from Africa, the Caribbean, or the Mediterranean, which is the inverse ofthe local population distribution; and, finally, although 51 drug addicts were screened, only one was positive for HBsAg, yet in our experience as many as 58% of drug addicts show evidence of past or current infection with HBV.
The reasons for inadequate screening are not clear but may include a failure to ask specifically about drug abuse or homosexuality; embarrassment at screening on grounds of race; concern at the time spent awaiting results; and even deliberate concealment by patients fearing that disclosure might adversely affect treatment. The screening must be regarded as unsatisfactory as appropriate precautions were not taken when unscreened patients were seen, many of whom were probably infected with HBV.
Our results show that neither a tattoo nor a history of hepatitis or jaundice more than 12 months previously is associated with an increased prevalence of infection with HBV; efficiency of screening would be improved, therefore,
